|
PFE's Revenue Growth by Quarter and Year
Pfizer Inc's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| PFE Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
January |
-
|
23,635.00
|
11,684.00
|
12,688.00
|
| III Quarter |
October |
-
|
24,094.00
|
12,131.00
|
12,680.00
|
| II Quarter |
July |
-
|
18,977.00
|
11,801.00
|
13,264.00
|
| I Quarter |
April |
25,661.00
|
14,582.00
|
12,028.00
|
13,118.00
|
| FY |
|
25,661.00
|
81,288.00
|
47,644.00
|
51,750.00
|
| PFE Revenue first quarter 2022 Y/Y Growth Comment |
Pfizer Inc achieved in the first quarter 2022, above Company average Revenue rise of 75.98% year on year, to $ 25,661.00 millions.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Revenue growth. While Pfizer Inc' s Revenue jump of 75.98% ranks overall at the positon no. 335 in the first quarter 2022.
|
| PFE Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
102.29 % |
-7.91 % |
-9.22 % |
| III Quarter |
October |
- |
98.62 % |
-4.33 % |
-4.65 % |
| II Quarter |
July |
- |
60.81 % |
-11.03 % |
-1.5 % |
| I Quarter |
April |
75.98 % |
21.23 % |
-8.31 % |
1.64 % |
| FY |
|
- |
70.62 % |
-7.93 % |
-3.54 % |
PFE Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
-1.91 % |
-3.68 % |
0.06 % |
| III Quarter |
October |
- |
26.96 % |
2.8 % |
-4.4 % |
| II Quarter |
July |
- |
30.14 % |
-1.89 % |
1.11 % |
| I Quarter |
April |
8.57 % |
24.8 % |
-5.2 % |
-6.15 % |
| FY (Year on Year) |
|
- |
70.62 % |
-7.93 % |
-3.54 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 68.78 % |
1.12 % |
-51.77 % |
| (Dec 31 2013) |
|
(Sep. 30, 2015) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 68.78 % |
1.12 % |
-51.77 % |
| (Dec 31 2013) |
|
(Sep. 30, 2015) |
|
| Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Pfizer Inc's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 42.3 % |
1.4 % |
-17.64 % |
| (Dec. 30. 2009) |
|
|
| PFE's I. Quarter Q/Q Revenue Comment |
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential Revenue increase of 8.57%, to $ 25,661.00 millions, from $23,635.00 millions in the forth quarter.
Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Pfizer Inc's Revenue growth quarter on quarter, overall rank is 745. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 42.3 % |
1.4 % |
-17.64 % |
| (Dec. 30. 2009) |
|
|
| PFE's I. Quarter Q/Q Revenue Comment |
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential Revenue increase of 8.57%, to $ 25,661.00 millions, from $23,635.00 millions in the forth quarter.
Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Pfizer Inc's Revenue growth quarter on quarter, overall rank is 745. |
|
Pfizer Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Apr 03 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Oct 03 2021) |
12 Months Ending
(Jul 04 2021) |
12 Months Ending
(Apr 04 2021) |
| Cumulative Revenue 12 Months Ending |
$ 92,367.00 |
$ 81,288.00 |
$ 69,337.00 |
$ 57,374.00 |
$ 50,198.00 |
| Y / Y Revenue Growth (TTM) |
84.01 % |
70.62 % |
42.53 % |
16.62 % |
-0.91 % |
| Year on Year Revenue Growth Overall
Ranking |
# 301 |
# 513 |
# 706 |
# 1392 |
# 2082 |
| Seqeuential Revenue Change (TTM) |
13.63 % |
17.24 % |
20.85 % |
14.3 % |
5.36 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 335 |
# 745 |
# 405 |
# 406 |
# 786 |
| Cumulative Revenue growth
Comment |
With 84.01% annual Revenue growth, Pfizer Inc would report a record annual Revenue growth if the fiscal year would end on Apr 03 2022.
In the Healthcare sector 62 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 301, from total ranking in previous quarter at 513. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
68.78 % |
1.12 % |
-51.77 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
84.01 % |
4.34 % |
-19.02 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 37 |
| Sector |
# 81 |
| S&P 500 |
# 335 |
|
| Cumulative Revenue growth
Comment |
With 84.01% annual Revenue growth, Pfizer Inc would report a record annual Revenue growth if the fiscal year would end on Apr 03 2022.
In the Healthcare sector 62 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 301, from total ranking in previous quarter at 513. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
68.78 % |
1.12 % |
-51.77 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
84.01 % |
4.34 % |
-19.02 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 37 |
| Sector |
# 81 |
| S&P 500 |
# 335 |
| Companies with similar Revenue growth for the quarter ending Apr 03 2022 within Healthcare Sector | Y/Y Change % | Revenue for the quarter ending Apr 03 2022 | | Pfizer Inc |  75.98% | $ 75.977 millions |
|
